Minute Insight: Abbott’s Libre 3 Finds Route To NHS Patients With YpsoMed And CamDiab Partnership

Abbott’s flagship CGM, the FreeStyle Libre 3, will soon become available in the UK through the National Health Service as part of a hybrid closed-loop system utilizing Ypsomed and CamDiab’s technologies.  

Minute Insight
• Source: Informa/Alamy

Abbott Laboratories’ FreeStyle Libre 3 continuous glucose monitor (CGM) is now authorized in the UK to be used with Ypsomed’s YpsoPump and CamDiab’s CamAPS FX mobile app in type I diabetics.

Patients will be able to access the system through the NHS.

More from Diabetic Care

More from Device Area